We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
-17%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.05B
AUM Growth
-$223M
Cap. Flow
+$34.7M
Cap. Flow %
3.3%
Top 10 Hldgs %
48.18%
Holding
82
New
3
Increased
31
Reduced
13
Closed
7

Top Buys

Rank Stock Value
1
TCMD icon
Tactile Systems Technology
TCMD
+$26.6M
2
TNDM icon
Tandem Diabetes Care
TNDM
+$23.1M
3
RARE icon
Ultragenyx Pharmaceutical
RARE
+$21.2M
4
PLRX icon
Pliant Therapeutics
PLRX
+$19.5M
5
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$17.7M

Top Sells

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$146M
2
ABCM
Abcam PLC
ABCM
+$17.4M
3
KRYS icon
Krystal Biotech
KRYS
+$11.9M
4
HALO icon
Halozyme
HALO
+$11.1M
5
OFIX icon
Orthofix Medical
OFIX
+$10.9M

Sector Composition

Rank Sector Weight
1 Healthcare 95.63%
2 Communication Services 4.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSTL icon
76
Castle Biosciences
CSTL
$849M
– –
-160,126
Closed -$2.2M
KRYS icon
77
Krystal Biotech
KRYS
$10.1B
– –
-101,259
Closed -$11.9M
PFE icon
78
Pfizer
PFE
$143B
– –
-140,235
Closed -$5.14M
ABCM
79
DELISTED
Abcam PLC
ABCM
– –
-710,745
Closed -$17.4M
AKU
80
DELISTED
Akumin Inc
AKU
– –
-1,575,098
Closed -$284K
SYNH
81
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-5,736
Closed -$242K
RETA
82
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-1,432,208
Closed -$146M
1 2 3
4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, First Light Asset Management held 82 positions worth $1.05B, down 17% from $1.28B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

First Light Asset Management deployed $34.7M of net new capital in Q3 2023, opening 3 new positions and adding to 31 existing holdings. Its largest new stake was Structure Therapeutics: 374,412 shares worth $18.9M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier, followed by Communication Services.

On the sell side, the largest reduction was Halozyme, an estimated $11.1M trimmed.

  • First Light Asset Management's largest Q3 2023 buy was Structure Therapeutics: 374,412 shares worth $18.9M.
  • First Light Asset Management added most to Tactile Systems Technology in Q3 2023, an estimated $26.6M increase.
  • First Light Asset Management's biggest Q3 2023 reduction was Halozyme, cutting an estimated $11.1M.
  • First Light Asset Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $146M.
  • First Light Asset Management's ten largest holdings make up 48% of its $1.05B portfolio in Q3 2023.
  • First Light Asset Management opened 3 new positions and closed 7 in Q3 2023.
  • First Light Asset Management's portfolio value fell 17% quarter-over-quarter to $1.05B.

Based on First Light Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.